Medtronic reported better-than-expected Q3 earnings with an adjusted EPS of $1.30 compared to an estimated $1.26 and revenue of $8.095 billion versus an estimated $7.95 billion. The company raised its FY adjusted EPS forecast to $5.19-$5.21 from $5.13-$5.19 due to strong demand for heart devices. Medtronic's market cap is $112.25 billion. Allegion also exceeded profit estimates in Q4, aided by higher demand and price hikes for its security systems in commercial buildings. Vertiv saw its Q4 net income rise to $232.6 million, with revenue reaching $1.87 billion, slightly below the analyst estimate of $1.89 billion.